Biotech Breakthroughs - Advancing Diabetes Treatments: Exploring GLP-1s and Beyond

Tim Lugo speaks with fellow equity research analysts Margaret Kaczor Andrew and Andy Hsieh about the GLP-1 drug class and its impact on the management of obesity, including potential read-throughs to the medtech and the therapeutics sector.

Episode metadata supplied by the publisher feed · Published Oct 13, 2023

Embed this episode

Attribution link and audio player

Ready to play

Biotech Breakthroughs - Advancing Diabetes Treatments: Exploring GLP-1s and Beyond

0:00 28:34

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The William Blair Thinking Podcast?

This episode is 28 minutes long.

When was this The William Blair Thinking Podcast episode published?

This episode was published on October 13, 2023.

Can I download this The William Blair Thinking Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!